Results
|
2861.
|
|
|
2862.
|
|
|
2863.
|
|
|
2864.
|
|
|
2865.
|
|
|
2866.
|
|
|
2867.
|
|
|
2868.
|
|
|
2869.
|
|
|
2870.
|
|
|
2871.
|
|
|
2872.
|
|
|
2873.
|
|
|
2874.
|
|
|
2875.
|
|
|
2876.
|
|
|
2877.
|
|
|
2878.
|
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. [electronic resource] by
- Lincoff, A M
- Mark, D B
- Tcheng, J E
- Califf, R M
- Bala, M V
- Anderson, K M
- Davidson-Ray, L
- Knight, J D
- Cabot, C F
- Topol, E J
Producer: 20010104
In:
Circulation vol. 102
Availability: No items available.
|
|
2879.
|
|
|
2880.
|
|